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Introduction
　Nonalcoholic fatty liver disease （NAFLD） is the most common form of chronic liver 
disease, paralleling the epidemic of obesity 1, 2）.  NAFLD is dened as the accumulation of 
lipid, primarily triacylglycerols, in individuals who do not consume a large amount of alco-
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Abstract : Nonalcoholic steatohepatitis （NASH） is regarded as a hepatic mani-
festation of the metabolic syndrome which can progress to hepatic cirrhosis 
and hepatocellular carcinoma.  It is thought that matrix metalloproteinases 
（MMPs） play an important role in hepatic brosis and we previously reported 
a correlation between oxidative stress and MMP-9 expression.  However, the 
expression of MMPs and tissue inhibitors of metalloproteinases （TIMPs） in 
the progression of NASH is unclear.  In this study we used spontaneously 
hypertensive and hyperlipidemic rats （SHHR） fed a high-fat diet and 30% 
sucrose solution （HFDS） as a model for NASH, in order to clarify the 
relationships between oxidative stress, liver weight （LW）, MMPs and TIMPs at 
various time-points in the progression of NASH.  Male SHHR and Sprague-
Dawley （SD） rats were divided into four groups : SHHR-normal diet （ND）, 
SHHR-HFDS, SD-ND and SD-HFDS.  Hepatic brosis was clearly increased 
at 13 months in SHHR-HFDS, resembpling NASH.  LW and oxidative stress 
markers in plasma were increased in SHHR-HFDS compared to the other 
groups.  Oxidative stress was correlated with LW in all rats.  Expression 
of MMP-2, MMP-9, TIMP-1 and TIMP-2 mRNA, measured by real-time 
polymerase chain reaction, was increased in the liver of SHHR-HFDS at 13 
months.  This study suggests that oxidative stress, MMPs and TIMPs may play 
an important role in the progression of NASH.
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hol 3）.  Nonalcoholic steatohepatitis （NASH） is a progressive form of NAFLD that is diag-
nosed by histopathological features 4）.  NAFLD and NASH have been recently recognized as 
hepatic manifestations of lifestyle-related diseases 2, 5, 6）.
　Spontaneously hypertensive hyperlipidemic rats （SHHRs） were developed as a stable 
model of early vascular degeneration7）, since there are few rat models for atherosclerosis. 
SHHRs have persistently high systolic blood pressure （above 150 mmHg） and a plasma total 
cholesterol concentration above 150 mg/dL.  In addition, vascular intimal lesions and lipid 
deposits have been observed under the endothelial cells in the aorta of SHHRs, but not 
in spontaneously hyperlipidemic rats or controls 8）.  Moreover, invasive changes occur in the 
subendothelium of SHHR when nitric oxide production is inactivated, followed by a high fat 
diet and sucrose water treatment （HFDS）9）, and a previous study found visceral fat accumu-
lation and increased oxidative stress in SHHR-HFDS 10, 11）.  We have found brosis and cell 
inammation around the central vein, and fat accumulation in hepatocytes on liver histology 
in SHHR-HFDS ; thus we use SHHR-HFDS as a rat model of NASH.
　Systemic oxidative stress is associated with visceral fat accumulation and the metabolic 
syndrome 12）.  In addition, oxidative stress plays an important role in the progression of 
NASH 13）.  As we have shown in a previous study 11）, the diacron reactive oxidative metabo-
lites （d-ROMs） test can be used as an indicator of oxidative stress.
　Matrix metalloproteinases （MMPs） are zinc ion-dependent enzymes that help to regulate 
the extracellular matrix, cellular migration, and tissue remodeling 14）.  MMPs are associated 
with liver brosis ; in particular, MMP-2 and MMP-9 play important roles in the progres-
sion of liver brosis 15）, and MMP-9 activity and expression are associated with oxidative 
stress 16）.  Our previous studies showed that mRNA expression of MMP-9 in white blood 
cells （WBCs） is signicantly higher in SHHR-HFDS compared to other rats 11）.  Moreover, 
MMPs are tightly regulated by tissue inhibitors of metalloproteinases （TIMPs）17）.
　Therefore, in this study we examined SHHR-HFDS as a model of NASH to clarify the 
relationships between oxidative stress, liver weight （LW）, MMPs and TIMPs in the progres-
sion of NASH.
Materials and Methods
Animals and samples
　Four-month-old male SHHRs and SD rats were each divided into two groups : a control 
group fed a regular diet （ND ; CE2 ; CLEA Japan Inc., Tokyo, Japan） and a HFDS-fed 
group.  The regular diet comprised 8.9% water, 25.4% protein, 4.4% fat, 4.1% ber, 6.9% 
carbohydrate and 50.3% nitrogen-free extracts, containing 342.2 kcal/100 g.  The high-fat diet 
（HFD） consisted of 8.2% water, 23.4% protein, 11.0% fat, 3.8% ber, 6.3% carbohydrate, 
and 46.3% nitrogen-free extracts, containing 378.0 kcal/100 g.  Until the age of 4 months, 
the regular diet was available to all groups ad libitum.  Thereafter, the two HFDS groups 
received NG-nitro-L-arginine methyl ester （Nacalai Tesque Co., Kyoto, Japan） in the drink-
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ing water （100 mg/L） for 1 month, and then the high-fat diet with 30% sucrose solution ad 
libitum for 4, 6 and 8 months, thus we obtained rats of 9, 11 and 13 months of age.  The 
present study used SHHRs with a systolic blood pressure over 150 mmHg, as determined 
by the tailcuff method （PS-100 ; Riken Kaihatsu, Tokyo, Japan）.  The rats were housed in 
a semi-barrier system under controlled room temperature （23±1 ℃）, humidity （55±5%）, 
and lighting （lights on from 6 AM to 6 PM）.  All studies were conducted according to the 
“Guiding Principles for the Care and Use of Laboratory Animals” of Showa University 11）.
Preparation and biochemical determination of plasma samples
　Blood samples were taken from the inferior vena cava under pentobarbital anesthesia 
（35 mg/kg, intraperitoneal administration） and mixed with 3.2% sodium citrate solution in a 
volume ratio of 9 : 1.  After 15 minutes of centrifugation at 3,000 rpm, the supernatant, as 
citrated plasma, was used for analysis.  The rats were killed by decapitation and the liver 
and visceral fat （VisF） were isolated and weighed.
　Plasma levels of total cholesterol and total triglycerides were determined with com-
mercially available kits （Cholesterol E-test and Triglyceride E-test, respectively ; Wako Pure 
Chemical Industries Ltd., Tokyo, Japan）.  Plasma levels of aspartate aminotransferase （AST） 
and alanine aminotransferase （ALT） were determined using the Transaminase CII-test 
（Wako）10）.  Oxidative stress was measured in rat plasma using the d-ROMs test （Free Radi-
cal Elective Evaluator ; Wismerll Co., Ltd., Tokyo, Japan） by gently mixing 20μl of plasma 
sample and 1 mL of buffer solution in a cuvette, before adding 10μL of the chromogenic 
substrate.  After mixing, the cuvette was immediately incubated in the thermostatic block 
of the analyzer for 5 minutes at 37℃ and then the absorbance at 505 nm was recorded. 
Measurements are expressed as Carr units, with 1 Carr corresponding to 0.8 mg/L H2O2 11）.
Morphological study
　The fresh left lobe of liver was harvested from all rats and stored in saline on ice.  It 
was then dissected from the surrounding tissues and xed in 10% neutral buffered formalin 
（pH 7.4 ; Wako）.  Sections of the liver were stained with hematoxylin-eosin （HE） and Mas-
son trichrome （MT）.
Preparation of total RNA
　Total RNA was extracted from the median lobe of the rat liver.  Liver samples （80
～ 500 mg） and RNAiso Plus （2 mL ; Takara Bio, Shiga, Japan） were mixed, before total 
RNA was isolated using the Takara FastPure RNA kit and quantied by optical density 
（260 nm）.  Each RNA sample was diluted with RNase-free water and mRNA concentra-
tions were equalized.  Total RNA was reverse transcribed using the ExScriptTM RT reagent 
kit （Takara）.
Hiromichi TSUCHIYA, et al40
Quantitative real-time polymerase chain reaction
　Quantitative real-time polymerase chain reaction （Q-PCR） was used to quantify the 
mRNA levels of MMP-2, MMP-9, TIMP-1, TIMP-2, TIMP-3 and superoxide dismutase 1 
（SOD1） in rat liver.  The cDNAs were amplied using primers designed by ProbeFiber 
software （Roche Diagnostic K.K., Tokyo, Japan）.  Table 1 details the primers used, Roche 
Universal ProbeLibrary Probe numbers, and accession numbers.  Amplication was performed 
with a LightCycler （Roche） using the LightCycler TaqMan Master mix （Roche）.  The PCR 
reaction parameters were as follows : 95℃ for 10 minutes, 45 cycles （except MMP-9, only 
MMP-9 ; 40 cycles） of 10 seconds at 95℃ , 30 seconds at 60℃ , and 1 second at 72℃ . 
Fluorescence data were analyzed with LightCycler software （Roche）.  The mRNA levels were 
compared to 18 s rRNA as a standard, and relative expression ratios were obtained 11）.
MMP-2 and MMP-9 immunostaining in the liver
　Liver sections （5μm） were dewaxed in xylene and placed on slides in the glass slide 
chamber, which was lled with processing buffer （citric acid buffer, pH 6.0）.  Sections were 
blocked for 1 hour in phosphate-buffered saline （PBS） containing 5% normal goat serum 
and then exposed to primary antibody （rabbit polyclonal antibody, 1 : 200） against either rat 
MMP-2 （sc-10736 ; Santa Cruz Biotechnology, Inc., Santa Cruz, CA） or MMP-9 （AB19016 ; 
Millipore Co., Billerica, MA）, overnight at 4℃.  The slides were then washed in PBS and 
incubated with anti-rabbit IgG secondary antibody.  After being rinsed in PBS, tissues 
were nally counterstained with HE.  Immunostaining of sections was uniformly timed and 
assessed by microscopy 11）.
Statistical analysis
　Data were analyzed using the Mann-Whitney U-test.  Correlations were calculated by the 
Pearson’s product moment correlation coefcient.  All data are expressed as mean±S.E.M. 
P＜ 0.05 was considered signicant.
Table 1.  Nucleotide sequences of the primers used for polymerase chain reaction.
Gene Sequence Accession number Probe number
MMP-2
Sense primer 5’-ctccactacgcttttctcgaat-3’
NM_031054.2 #60
Antisense primer 5’-tgggtatccatctccatgct-3’
MMP-9
Sense primer 5’-cctctgcatgaagacgacataa-3’
NM_031055.1 #42
Antisense primer 5’-ggtcaggtttagagccacga-3’
TIMP-1
Sense primer 5’-cagcaaaaggccttcgtaaa-3’
NM_053819.1 #76
Antisense primer 5’-tggctgaacagggaaacact-3’
TIMP-2
Sense primer 5’-ctggacgttggaggaaagaa-3’
L31884.1 #12
Antisense primer 5’-acagagggtaatgtgcatcttg-3’
TIMP-3
Sense primer 5’-tgcaactttgtggagaggtg-3’
U27201.1 #123
Antisense primer 5’-aggcaagtagtagcaggacttgat-3’
SOD1
Sense primer 5’-ggtccagcggatgaagag-3’
NM_017050.1 #5
Antisense primer 5’-ggacacattggccacacc-3’
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Results
　Table 2 shows the level of body weight, VisF, hemoglobin A1C, total cholesterol, total trig-
lycerides, AST, ALT, and d-ROMs in the SD-ND, SD-HFDS, SHHR-ND and SHHR-HFDS 
groups.  There was no signicant change in body weight between the two SHHR groups. 
In both the SD and SHHR groups, VisF and LW （Fig. 1A） were either significantly 
elevated or tended to be elevated after ingestion of HFDS.  LW in SHHR-HFDS was 
signicantly increased at 11 and 13 months compared with other rats.  Plasma hemoglobin 
A1C, AST and ALT levels were unchanged among the SD and SHHR groups.  The level 
of oxidative stress （d-ROMs） in SHHR-HFDS was higher than in other rats at 9 and 13 
months.  A signicant positive correlation （Pearson r = 0.712, P＜ 0.0001） between LW and 
d-ROMs in all rats is shown in Fig. 1B.
　Photographs of the livers from 9-month-old rats are shown in Fig. 2.  The images of both 
the SD and SHHR groups show fatty liver caused by the HFDS feeding.  Fig. 3 shows the 
results of the morphological study with a representative sample of liver from each group of 
SHHRs and SD rats at 13 months, stained by HE and MT.  Hepatocyte ballooning and ste-
atosis are well recognized with HFDS feeding.  Severe brosis and cell inammation around 
the central vein were observed in SHHR-HFDS but only slightly detected in SD-HFDS. 
Figs. 4 and 5 are photomicrographs of the liver showing the immunostaining of MMP-2 and 
MMP-9, respectively.  In SHHR-HFDS, staining of MMP-2 was detected mainly in extracel-
lular spaces, while staining of MMP-9 was observed in the WBCs, hepatocytes, bile ducts 
and biliary canaliculi.  Staining of MMP-2 and MMP-9 was barely evident in the livers from 
the three other groups of rats.
　SOD1 mRNA expression in the liver of rats, measured by Q-PCR, is shown in Fig. 
6.  SOD1 mRNA expression in SHHR-HFDS decreased to 42% of SD-ND and 20% of 
SHHR-ND at 13 months.  MMP-2 and MMP-9 mRNA expression in rat liver, measured 
by Q-PCR, are shown in Figs. 7A and 7B, respectively.  In SHHR-HFDS, MMP-2 mRNA 
expression was increased 3.18, 2.76 and 16.6 fold at 9, 11 and 13 months, respectively, com-
pared to SD-ND at the same months.  SHHR-HFDS showed a time-dependent 1.65-, 8.83- 
and 49.47- fold increase in MMP-9 mRNA at 9, 11 and 13 months, respectively, compared to 
SD-ND.  TIMP-1, TIMP-2 and TIMP-3 mRNA expression in rat liver, measured by Q-PCR, 
are shown in Figs. 8A, 8B and 8C, respectively.  In SHHR-HFDS at 13 months, TIMP-
1 and TIMP-2 mRNA expression were increased 8.67 and 28.96 fold, respectively, compared 
to SD-ND.  There was little variation in TIMP-3 mRNA expression in all groups and no 
signicant differences were seen between SD-ND and SHHR-HFDS at 9 or 13 months.
Discussion
　The present study demonstrates that the increased LW associated with oxidative stress 
markers progressed to liver brosis.  In addition, MMP-2 and MMP-9 expression in SHHR-
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HFDS increased dramatically at 13 months with the progression of NASH.
　Several previous studies have established a relationship between obesity and lifestyle-
related diseases.  In particular, visceral obesity is directly correlated with the clustering of 
lifestyle-related diseases, leading to various ailments18-20）.  Our previous report showed that 
visceral fat accumulation is closely associated with increased oxidative stress 11）.  In the 
present study, there was also a signicantly positive relationship between VisF and LW in 
all groups, with the underlying pathological conditions of hypertension and hyperlipidemia 
having a weak yet direct effect on this relationship.  Moreover, NASH model rats developed 
intense brosis in the liver by 13 months of age.  The most accepted theory to explain 
the progression from simple NAFLD to NASH is the “two-hit hypothesis” wherein fat 
accumulation is sufcient to induce the progression to steatohepatitis, but renders the liver 
 
 
 
 
 
 
 
Fig. 1.   （A）Liver weight （LW） in Sprague-
Dawley rats on a normal diet （SD-ND）, 
SD-high fat diet with sucrose （SD-HFDS）, 
spontaneously hypertensive hyperlipidemic 
rats-ND （SHHR-ND） and SHHR-HFDS. 
Data are expressed as mean ± S.E.M. ＊P
＜ 0.05, SHHR-HFDS vs SD-HFDS, SD-ND, 
and SHHR-ND at 13 months. ＊＊P ＜
0.05, SHHR-HFDS vs SHHR-ND; SD-ND 
vs SD-HFDS at 11 months. ＊＊＊P ＜ 0.05, 
SHHR-HFDS vs SHHR-ND; SD-ND vs 
SD-HFDS at 9 months.
（B）Correlation between oxidative stress 
and liver weight （LW）. A significant 
positive correlation （Pearson r = 0.71, P＜
0.0001） between LW and diacron reactive 
oxidative metabolites （d-ROMs） was 
observed in all rats.
A
B
Hiromichi TSUCHIYA, et al44
Fig. 2.   Liver photographs after abdominal dissection in （A） 
Sprague-Dawley rats on a normal diet （SD-ND）, 
（B） SD-high-fat diet with sucrose （SD-HFDS）, （C） 
spontaneously hypertensive hyperlipidemic rats-ND （SHHR-
ND） and （D） SHHR-HFDS at 9 months of age.
Fig. 3.  Histological changes in the liver of rats at 13 months of age. 
Panels （A）-（D） shows hematoxylin-eosin staining and （E）-（H） shows Masson trichrome （MT） staining in: 
（A） and （E）, Sprague-Dawley rats on a normal diet （SD-ND）; （B） and （F）, SD-high-fat diet with sucrose 
（SD-HFDS）; （C） and （G）, spontaneously hypertensive hyperlipidemic rats-ND （SHHR-ND）; and （D） 
and （H）, SHHR-HFDS. Hepatocyte ballooning and cell inammation are indicated by the yellow arrows. 
Fibrosis is indicated by the yellow arrows following MT staining in （E）-（H）. Original magnication ×100.
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Fig. 4.  Immunostaining of MMP-2 in the liver. 
MMP-2 stained brown with yellow arrows indicating the staining of MMP-2. （A） Sprague-Dawley 
rats on a normal diet （SD-ND）, （B） SD-high-fat diet with sucrose （SD-HFDS）, （C） spontaneously 
hypertensive hyperlipidemic rats-ND （SHHR-ND） and （D） SHHR-HFDS. Original magnication ×100.
Fig. 5.  Immunostaining of MMP-9 in the liver. 
MMP-9 stained brown with yellow arrows indicating the staining of MMP-9. （A） Sprague-Dawley 
rats on a normal diet （SD-ND）, （B） SD-high-fat diet with sucrose （SD-HFDS）, （C） spontaneously 
hypertensive hyperlipidemic rats-ND （SHHR-ND） and （D） SHHR-HFDS. Original magnication ×100.
Fig. 6.   SOD1 mRNA expression in the liver of 
Sprague-Dawley rats on a normal diet 
（SD-ND）, SD-high-fat diet with sucrose 
（SD-HFDS）, spontaneously hypertensive 
hyperlipidemic rats-ND （SHHR-ND） 
and SHHR-HFDS, relative to SD-ND, 
as determined by quantitative real-time 
polymerase chain reaction. Data are shown 
as mean ± S.E.M. ＊P＜ 0.05, SHHR-ND 
vs SD-ND, SD-HFDS and SHHR-HFDS 
at 9, 11 and 13 months.
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more susceptible to a “second hit” that, once imposed upon the steatotic liver, causes 
further aberrations that culminate in the development of NASH 13, 21）.  One of the key fac-
tors in this “second hit” is oxidative stress 13）.  Indeed, our NASH model rats had increased 
d-ROMs levels but not increased SOD1 expression.  However, the livers of the SD-HFDS 
rats did not progress from simple NAFLD to NASH, because the oxidative stress markers 
in these rats were not increased, as they were in the NASH model rats.  Thus, this study 
suggests that the progression from simple NAFLD to NASH requires oxidative stress in this 
model.
　The remodeling process of damaged liver tissue includes the activation of quiescent 
A
B
Fig. 7.   （A） MMP-9 and （B） MMP-2 mRNA 
expression in the liver of Sprague-Dawley 
rats on a normal diet （SD-ND）, SD-high-
fat diet with sucrose （SD-HFDS）, 
spontaneously hypertensive hyperlipidemic 
rats-ND （SHHR-ND） and SHHR-
HFDS, relative to SD-ND, as determined 
by quantitative real-time polymerase 
chain reaction. Data are shown as mean
± S.E.M. ＊P ＜ 0.05, SHHR-HFDS vs 
SD-ND, SD-HFDS and SHHR-ND at 13 
months.
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Fig. 8.   （A） TIMP-1, （B） TIMP-2 and （C）
TIMP-3 mRNA expression in the liver 
of Sprague-Dawley rats on a normal 
diet （SD-ND）, SD-high-fat diet with 
sucrose （SD-HFDS）, spontaneously 
hypertensive hyperlipidemic rats-
ND （SHHR-ND） and SHHR-HFDS, 
relative to SD-ND, as determined by 
quantitative real-time polymerase chain 
reaction. Data are shown as mean ± 
S.E.M. （A）: ＊P ＜ 0.05, SHHR-HFDS 
vs SD-HFDS and SHHR-ND at 13 
months. （B）: ＊P ＜ 0.05, SHHR-HFDS 
vs SD-ND, SD-HFDS and SHHR-ND 
at 13 months.
A
B
C
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hepatic stellate cells （HSCs） into broblast-like cells, which then produce matrix degradation 
proteins, collectively known as the MMP family 22, 23）.  From the known MMPs only a few 
are expressed in liver tissue 15）, and it is known that MMP-9 is produced at very low levels 
in normal liver 24）.  In the present study, MMP-9 mRNA expression increased dramatically 
in 13-month-old SHHR-HFDS, as it was produced at very low levels in the control liver. 
MMP-9 is produced by Kupffer cells in primary culture, by IL-1β- and TNF-α-stimulated 
hepatocytes, IL-1α-stimulated HSCs, and in carbon tetrachloride-induced liver injury 15）.  In 
liver disease, HSCs and inammatory mononuclear cells （e.g. lymphocytes and neutrophils） 
are also a source of MMP-9 15, 24, 25）.  In our previous study, SHHR-HFDS exhibited a 
higher MMP-9 expression in WBCs than other rat groups 11）, and MMP-9 mRNA expression 
and activity is high in monocytes 26）.  In the present study, MMP-9 immunolabeled WBCs 
appeared in the SHHR-HFDS liver at 13 months, but did not appear in the other rat 
groups.  Moreover, the immunolocalization of MMP-9 in hepatocytes, bile ducts and biliary 
canaliculi reected the fact that these NASH model rats were severely affected and almost 
at a stage of hepatic cirrhosis in a part of NASH liver.  TIMP-1 is a natural inhibitor of 
MMP, especially pro-MMP-9, acting to maintain the structural integrity of basement mem-
branes and protects them from degeneration 27）.  The relative balance of MMP-9 and TIMP-
1 is thus important in approximating the value of absolute MMP-9 activity 17）. In the present 
study, TIMP-1 expression in the liver was increased in SHHR-HFDS at 13 months, but the 
increase in MMP-9 was bigger than the increase in TIMP-1, thus MMP-9 activity would be 
increased in SHHR-HFDS at 13 months.
　MMP-2 is constitutively expressed by many cell types, and its promoter is TATA-less, like 
many of the so-called housekeeping genes 28）.  In the present study, there were only small 
changes in MMP-2 mRNA expression up until 11 months, however expression increased 
markedly in SHHR-HFDS at 13 months compared with the other groups.  Oxidative stress 
is thought to stimulate MMP-2 upregulation via signal-regulated kinase 1/2 and phosphatidyl 
inositol 3-kinase on HSCs 29）.  Interestingly, TIMP-2 also inhibits all known members of the 
MMP family, but associates with membrane type 1-MMP and MMP-2 at the cell surface 
and regulates MMP-2 activation 17）.  In the present study, TIMP-2 expression in liver was 
increased markedly in SHHR-HFDS at 13 months, enough to activate MMP-2 pro-type, 
leading to the immunolocalization of MMP-2 in extracellular spaces in SHHR-HFDS liver at 
13 months.  Hemmann and colleagues have suggested that continuous MMP-2 overexpres-
sion in HSCs with its proliferation and migration sequelae may foster the progression of 
fibrosis 15）.  TIMP-3 is a natural inhibitor of MMPs and a disintegrin and metalloprotei-
nase-17 30）, but it did not change greatly in our present study.
　In conclusion, the present study suggests that increased oxidative stress induces upregulation 
of MMP-2, MMP-9 and TIMP-2, followed by progression to brosis in the liver of NASH 
model rats.  Regulation of the MMP family may lead to suppression of the progression of 
hepatic brosis.  The SHHR model may help in the elucidation and treatment of NASH.
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